Skip to main content
. 2024 Jun 19;13(12):3587. doi: 10.3390/jcm13123587

Table 2.

Clinical characteristics of the studied subgroups.

Parameter Obesity
(A, n = 98)
Overweight
(B, n = 83)
Control Group
(C, n = 69)
p < 0.05
age (years) 61.18 ± 11.07 53.40 ± 13.70 58.83 ± 15.33 ns
sex (%/n)
   Male 50.0/49 50.6/42 18.8/13 A, B vs. C
   Female 50.0/49 49.4/41 81.2/56 A, B vs. C
height (cm) 168.14 ± 9.65 168.64 ± 10.36 164.76 ± 8.78 ns
weight (kg) 95.09 ± 13.24 78.39 ± 11.10 62.02 ± 7.99 A vs. B, C
B vs. C
BMI (kg/m2) 33.62 ± 3.26 27.56 ± 1.34 22.86 ± 1.71 A vs. B, C
B vs. C
waist circumference (cm) 107.29 ± 10.16 95.29 ± 8.55 79.72 ± 7.55 A vs. B, C
B vs. C
hip circumference (cm) 115.23 ± 7.32 104.26 ± 5.23 93.83 ± 14.14 A vs. B, C
B vs. C
WHR 0.93 ± 0.08 0.91 ± 0.09 1.05 ± 1.56 ns
hypertension (%/n) 64.3/63 50.6/42 39.1/27 A, B vs. C
myocardial infarction (%/n) 7.1/7 7.2/6 4.3/3 ns
stroke (%/n) 2.0/2 3.6/3 2.9/2 ns
atrial fibrillation (%/n) 8.2/8 12.0/10 5.8/4 ns
deep vein thrombosis (%/n) 7.1/7 1.2/1 1.4/1 ns
type 2 diabetes (%/n) 21.4/21 10.8/9 4.3/3 A vs. C
thyroid disease (%/n) 16.3/16 13.2/11 20.3/14 ns
smoking (%/n) 9.2/9 15.8/13 15.9/11 ns

BMI—body mass index, WHR—waist-hip ratio, ns—not significant.